Verification of the Efficacy and Safety of the BAROSTIM NEO System in the Treatment of Drug Resistant Hypertension | MicrobiomeTrials← Back to trialsNCT01471834
Verification of the Efficacy and Safety of the BAROSTIM NEO System in the Treatment of Drug Resistant Hypertension
RecruitingNAINTERVENTIONAL
Trial Details
Start: 2011-06Est. Completion: 2012-05
Enrollment target: 40 participants Locations- University of Calgary, Calgary, Alberta, Canada
- University of Alberta - Edmonton, Edmonton, Alberta, Canada
- London-Lawson Health Research Institute, London, Ontario, Canada
- University Hospital Cologne, Cologn, Germany
- University Hospital Duesseldorf, Düsseldorf, Germany
- Goettingen-Georg August University, Göttingen, Germany
- Midizinische Hochschule Hannover, Hanover, Germany
- Klinkum St. George Leipzig, Leipzig, Germany
- Maastricht University, Maastricht, Netherlands
Other microbiome trials you might be interested in
Systemic SclerosisScleroderma
The purpose of this study is to evaluate the efficacy and safety of treatment with subcutaneous anifrolumab versus place…
Scottsdale, United StatesEst. completion Jan 6, 2027
Sacral FractureOsteoporotic Fracture
This study is designed to determine whether sacroplasty, a minimally invasive procedure to stabilize sacral fractures, i…
Hull, United KingdomEst. completion Dec 2029
Recruiting
Chronic Kidney Disease Stage 5End Stage Renal Disease
The main purpose of this trial is to determine whether the addition of the VIEWER virtual care platform to usual care wi…
Winnipeg, CanadaEst. completion Mar 30, 2027